Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
about
The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory painThe role of long chain fatty acids and their epoxide metabolites in nociceptive signalingSoluble epoxide hydrolase: gene structure, expression and deletionInhibition of soluble epoxide hydrolase limits niacin-induced vasodilation in miceGenetic variation in soluble epoxide hydrolase: association with outcome after aneurysmal subarachnoid hemorrhageSoluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single AgentEpoxyeicosanoid signaling in CNS function and diseaseAltered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injuryAn update on the blood vessel in migraineCytochrome P450 2C24: Expression, Tissue Distribution, High-Throughput Assay, and Pharmacological Inhibition.Role of epoxyeicosatrienoic acids as autocrine metabolites in glutamate-mediated K+ signaling in perivascular astrocytes.Epoxyeicosatrienoic acids are endogenous regulators of vasoactive neuropeptide release from trigeminal ganglion neuronsRhythmic expression of cytochrome P450 epoxygenases CYP4x1 and CYP2c11 in the rat brain and vasculature.Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injury.Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury.The effects of hypertension on the cerebral circulation.Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures.Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice.Differential effect of amyloid β on the cytochrome P450 epoxygenase activity in rat brainPotassium channels and neurovascular coupling.Contribution of epoxyeicosatrienoic acids to the cerebral blood flow response to hypoxemia.Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in miceSoluble epoxide hydrolase: sex differences and role in endothelial cell survival.Plasticity of cytochrome P450 isozyme expression in rat trigeminal ganglia neurons during inflammation.Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma.Endocannabinoids in cerebrovascular regulation.Genetic enhancement of microsomal epoxide hydrolase improves metabolic detoxification but impairs cerebral blood flow regulation.Modern and Evolving Understanding of Cerebral Perfusion and AutoregulationP450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.Cytochrome P450 eicosanoids in cerebrovascular function and disease.Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.Soluble epoxide hydrolase inhibition Promotes White Matter Integrity and Long-Term Functional Recovery after chronic hypoperfusion in mice20-Hydroxyeicosatetraenoic Acid Inhibition by HET0016 Offers Neuroprotection, Decreases Edema, and Increases Cortical Cerebral Blood Flow in a Pediatric Asphyxial Cardiac Arrest Model in Rats.Marmoset cytochrome P450 2J2 mainly expressed in small intestines and livers effectively metabolizes human P450 2J2 probe substrates, astemizole and terfenadine.Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia.Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls
P2860
Q21203935-A2BF2EEE-5F9C-4410-82AE-F1673205AB61Q28248377-CD87FE9F-AE25-4DE7-85A6-64A758D3FB4EQ28291292-D9ECF4F8-FAA1-4524-964E-F0BCDBC3978EQ28386328-09890C12-B035-4C88-82FE-A16C6F2D195EQ28390328-A2A8B1BC-6DA9-4476-BAD6-76D7EEC6A22FQ28391163-7FDAAD72-FA25-4CBC-84C4-55B12D55C88AQ28394441-274D7AA8-353D-4C11-B8B3-3059D83AE6ABQ28396471-3E148DEC-0585-4F13-837B-BAEE7B838184Q33880507-A167FE17-AEB5-418A-A683-3F58854AC898Q33939653-1CBC3FB6-DE26-4139-A92F-A47E4FC415B1Q34304984-FC829708-533B-4835-BDE0-772FD149DEBBQ34376228-89A4747D-90AD-488B-B3A9-EFC5729DBA9DQ34627489-3FAD4CD2-AAD3-47D9-A924-E565A205B31DQ34667954-E2663088-88C9-4D8C-BCEC-8FEF7DD48296Q34705038-E8B0F779-DDFA-4940-B593-FA34AC42F4E8Q34790113-D948A6DF-52A2-42F4-AB52-29537DE2F852Q34842312-9947FDC5-4685-4469-BA65-CFD0AD7714E7Q34969971-6F456C1E-4835-4B8F-B678-2544904B3CA3Q35243119-80276871-A2D3-49CC-A324-3979ACCC20BBQ35510178-C5AEC77D-56A6-49AF-B178-E02A42B15938Q35581966-E137C426-13D0-48F0-93A8-660CBBB0E7AFQ35640579-E8CBF354-1FE2-4530-822A-546BF70DB30BQ36160027-C4E91D1C-454A-4A5E-AEDE-09DAF7870EF9Q36199024-02F348B9-CFCC-4F03-9E03-6F3450F31449Q36538782-ECE7CED0-AA9A-419B-8BC6-9F76E3C6A164Q36895795-9F611478-7D16-4850-885C-332158054FC6Q37408068-CE693FA9-BF82-4492-8A8C-DCDC203D4BF5Q37682954-78EDD5EC-B4BD-4383-9D01-C383345283ADQ38744600-C7D9F702-B68F-4354-BE33-122E42CDCB0FQ39249384-C4520C19-C25B-4F7D-B131-02B64A901D65Q39319956-2B3C720B-17FF-4467-A977-C35D83DD0E2DQ39392465-CA2BB308-8A5F-4B31-BC19-260A95312925Q41354081-570ACF14-86F4-4569-B953-C07D2670D647Q43185820-654A5542-AE01-4082-9F66-EE4F17263726Q48889351-100ADB63-DB00-40CE-A5A7-0D5FEC583CDBQ55197614-3593537A-7420-4921-A454-49FBD54A535AQ57313058-C9969DDB-B5C9-4FCF-88FE-7DB6DD4C2B37
P2860
Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
@ast
Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
@en
type
label
Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
@ast
Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
@en
prefLabel
Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
@ast
Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
@en
P2093
P2860
P1476
Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
@en
P2093
Jeffrey J Iliff
Nabil J Alkayed
Ruikang Wang
P2860
P304
P356
10.1152/AJPHEART.00950.2008
P577
2009-03-20T00:00:00Z